SCHEMBL19197804

SCHEMBL19197804

Cc1ccc2cc(CCc3ccc4cc(-c5ccc(C)c(F)c5F)ccc4c3)ccc2c1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.37
CYP1A2 P05177 2/20 0.37
ESR1 P03372 2/20 0.36
ESR2 Q92731 2/20 0.36
FFAR1 O14842 3/20 0.36
ABL1 P00519 2/20 0.35
FFAR4 Q5NUL3 3/20 0.34
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
BACE1 P56817 1/20 0.33
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19197803 0.94 ESR1 (0.36) CYP2A6CYP1A2ESR1ESR2FFAR1
SCHEMBL19196919 0.94 CYP2A6 (0.37) CYP2A6CYP1A2FFAR1FFAR4PTGS1
SCHEMBL21908510 0.89 CYP2A6 (0.46) CYP2A6CYP1A2ESR1ESR2ABL1
SCHEMBL19196920 0.84 CYP2A6 (0.36) CYP2A6CYP1A2FFAR1FFAR4PTGS1
SCHEMBL19798106 0.80 BACE1 (0.38) CYP2A6CYP1A2FFAR1FFAR4PTGS1
SCHEMBL18503372 0.80 CYP1A2 (0.39) CYP2A6CYP1A2FFAR1FFAR4PTGS1
SCHEMBL18194865 0.80 CYP2A6 (0.50) CYP2A6CYP1A2ESR1ESR2ABL1
SCHEMBL18627004 0.79 KDM4E (0.46) CYP2A6CYP1A2FFAR1FFAR4PTGS1
SCHEMBL19197845 0.79 HRH3 (0.37) FFAR1FFAR4PTGS1PTGS2HRH3
SCHEMBL19197050 0.79 CYP2A6 (0.36) CYP2A6CYP1A2PTGS1PTGS2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3173457-B1 LIQUID-CRYSTAL COMPOSITION AND LIQUID-CRYSTAL DISPLAY ELEMENT OBTAINED USING SAME DAINIPPON INK & CHEMICALS (JP) 2019-06-05 EP disclosed
US-20180030346-A1 NEMATIC LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT MANUFACTURED USING SAME DIC CORPORATION (JP) 2018-02-01 US disclosed
US-20170218271-A1 LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME DIC CORPORATION (JP) 2017-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180030346-A1 NEMATIC LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT MANUFACTURED USING SAME LBR, VSIR, KIF23 CYP2A6 4747/4885CYP1A2 4385/4885ESR1 4398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.